欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL

2026-07-05
Dr Reddy’s Chief On Gains From gRevlimid, Patient Capital To Drive Innovation In India

2026-07-05
Rare Disease Could Boost China’s Growing Influence Over Early-Stage RD

2026-07-04
UK Asks Industry To Identify High-Impact Areas For Animal Testing Alternatives

2026-07-04
Cancer Drug Suppliers In Limelight As Oxaliplatin Added To US List Of Shortages

2026-07-04
What does practical sustainability in API manufacturing really look like?

2026-07-04
Prestige Biopharma And Charles River Align On Biosimilar Development

2026-07-04
Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

2026-07-03
What’s The Recourse For Global Regulators As Cancer Drugs’ Supply Falls Short?

2026-07-03
Second Time Lucky For SB’s Byooviz? Relaunch Offers Fresh Start In US Lucentis Biosimilar Market

2026-07-03
Rare Disease Could Boost China’s Growing Influence Over Early-Stage RD

2026-07-03
Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease

2026-07-03